New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
07:20 EDTNAVBNavidea price target raised to $5 from $3 at JMP Securities
JMP Securities increased its price target on Navidea after the company reported higher than expected Q2 Lymphoseek sales and operating income. The firm thinks the company has a number of significant growth drivers and keeps an Outperform rating on the shares.
News For NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 24, 2015
07:32 EDTNAVBNavidea to register shares for dual listing on TASE
Navidea Biopharmaceuticals announced that it has filed an application for registration of shares of its common stock for dual listing on the Tel-Aviv Stock Exchange, or TASE. Dual listing on the TASE is allowed in the U.S. and Israel without any additional regulatory requirements for companies whose shares are listed on certain accredited stock exchanges outside of Israel, including the NYSE MKT.
August 20, 2015
07:31 EDTNAVBNavidea reports publication of Lymphoseek comparative results in pain study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use